Dr. Reddy`s Laboratories PEG Ratio

The latest PEG ratio for RDY is -43.15. That is below the Healthcare sector average of 2.89. Investors often review this figure alongside Dr. Reddy`s Laboratories's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, RDY currently prints -43.15 for PEG ratio, while the sector average sits near 2.89. That is roughly 1592.8% below the sector mean. Large gaps often invite a closer look at Dr. Reddy`s Laboratories's growth, margins, and balance sheet.

A PEG ratio of -43.15 for Dr. Reddy`s Laboratories is not 'good' or 'bad' on its own. Compare it with the peer average (2.89) and with RDY's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting RDY's PEG ratio (-43.15), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Dr. Reddy`s Laboratories's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.